scholarly article | Q13442814 |
P50 | author | Zhiyong Lu | Q19857266 |
Emily Chew | Q24266614 | ||
Anand Swaroop | Q30506132 | ||
Rinki Ratnapriya | Q83230798 | ||
Elvira Agrón | Q83234331 | ||
Traci E Clemons | Q92993074 | ||
Age-Related Eye Disease Study 2 Research Group | Q117242065 | ||
P2093 | author name string | Ayush Singhal | |
Michael Simmons | |||
Freekje van Asten | |||
Tiarnan D Keenan | |||
P2860 | cites work | Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA | Q24317658 |
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration | Q24682343 | ||
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes | Q28943546 | ||
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors | Q30239897 | ||
Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial | Q30457640 | ||
LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis | Q32125469 | ||
Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study | Q33586908 | ||
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations | Q33808357 | ||
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration | Q34066021 | ||
Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. | Q34164826 | ||
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis | Q34437319 | ||
Age-related macular degeneration: genetics and biology coming together | Q34440797 | ||
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk | Q34452441 | ||
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial | Q34490891 | ||
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 | Q34620551 | ||
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
Clinical characteristics and current treatment of age-related macular degeneration | Q34930298 | ||
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data | Q35052005 | ||
Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials | Q35995626 | ||
Text mining for precision medicine: automating disease-mutation relationship extraction from biomedical literature | Q36001233 | ||
Text Mining for Precision Medicine: Bringing Structure to EHRs and Biomedical Literature to Understand Genes and Health | Q36180839 | ||
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. | Q36194390 | ||
Text Mining Genotype-Phenotype Relationships from Biomedical Literature for Database Curation and Precision Medicine | Q36207982 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants | Q36556369 | ||
Retinal precursors and the development of geographic atrophy in age-related macular degeneration. | Q36991543 | ||
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) | Q36996217 | ||
ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration | Q37149450 | ||
Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7 | Q37166967 | ||
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration | Q37265929 | ||
Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits | Q37724216 | ||
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. | Q38238059 | ||
Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration | Q38423796 | ||
The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration | Q38448712 | ||
Risk factors and biomarkers of age-related macular degeneration | Q38828895 | ||
The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target | Q39024579 | ||
The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences | Q40438027 | ||
Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy | Q46654633 | ||
A functional variant in the CFI gene confers a high risk of age-related macular degeneration | Q47073487 | ||
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration | Q48240873 | ||
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy | Q83597754 | ||
Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population | Q85017767 | ||
P433 | issue | 4 | |
P921 | main subject | phenotype | Q104053 |
eye disease | Q3041498 | ||
macular degeneration | Q27429789 | ||
P304 | page(s) | 559-568 | |
P577 | publication date | 2017-10-30 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. | |
P478 | volume | 125 |
Q92126793 | Application of magnetic nanoparticles in nucleic acid detection |
Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
Q64246936 | Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent |
Q57826004 | Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies |
Q58594328 | The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration |
Search more.